ArticleAmerican journal of translational research2026
Thoracoscopic segmentectomy versus lobectomy for early-stage non-small cell lung cancer: efficacy, postoperative recovery, and prognosis.
Article in American journal of translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo compare the clinical outcomes of thoracoscopic segmentectomy (TSE) and lobectomy (TLE) in early-stage non-small cell lung cancer (NSCLC) patients.
methodsA total of 129 patients with early-stage NSCLC (ES-NSCLC) treated at the First People's Hospital of Zunyi between May 2022 and May 2024 were retrospectively enrolled. Patients were divided into a control group (n=62; undergoing TLE) and a research group (n=67; undergoing TSE) based on their surgical approach. Surgical outcomes, intraoperative hemorrhagic blood loss, number of lymph nodes resected, surgical duration, chest drain duration and volume, minute ventilation, length of hospital stay, Visual Analogue Scale (VAS) scores, pulmonary function (PF), arterial blood gas parameters, postoperative complications, and prognosis was compared between the two groups.
resultsResection efficacy, lymph node harvest, chest tube duration, overall morbidity rate, and 1-year survival/recurrence were comparable between the two groups. However, TSE was associated with reduced intraoperative bleeding, shorter procedure time, lower postoperative drainage volume, shorter hospitalization time, and lower pain scores on postoperative days 1 and 5, with better minute ventilation values. Although PF and partial pressure of oxygen (PaO
conclusionTSE for ES-NSCLC is associated with improved ventilation volume, shorter hospital stays, alleviated postoperative pain, and better preservation of PF and arterial blood gas parameters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.